Clinical Trial Update: Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing intravenous and sublingual isosorbide dinitrate for relief of acute anginal episodes in acute coronary syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• intravenous isosorbide dinitrate (isosorbide dinitrate)
• sublingual isosorbide dinitrate (isosorbide dinitrate)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Unstable Angina, Myocardial Infarction | Phase 4 | Status: WITHDRAWN